Volume Alert - SUSQ 13.08 Susquehanna Bancshares $SUSQ Hit

New Post Public Reply Private Reply Replies (0) Message Board

Nov 14, 2014 at 12:48 PM

Volume Alert - SUSQ 13.08 Susquehanna Bancshares $SUSQ Hit a high today of 13.10 Closing the day 10:30 at 13.08 +0.02 +0.15% With a day low of 13.03 and a total volume of 1,768,005.

SUSQ Recent Posts: http://investorshangout.com/Susquehanna-Bancs...USQ-55567/

SUSQ Susquehanna Bancshares Recent Headline News

INVESTOR ALERT: Levi & Korsinsky, LLP Launches Investigation into the Board of Directors of Susquehanna Bancshares, Inc. Regarding the Fairness of the Sale of the Company to BB&T Corporation -- SUSQ
PR Newswire - 3 mins ago
Levi & Korsinsky is investigating the Board of Directors of Susquehanna Bancshares, Inc. ("Susquehanna" or "the Company"

(Nasdaq: SUSQ) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to BB&T Corporation (NYSE: BBT).
BBT: 37.60 (+0.02), SUSQ: 13.13 (+0.07)

Nasdaq stocks posting largest volume increases
AP - Thu Nov 13, 5:05PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
RESN: 7.18 (-0.01), FCVA: 4.35 (-0.10), GLBZ: 12.40 (-0.35), VGGL: 2.76 (-0.16), RDI: 11.95 (-0.03), CRDC: 0.87 (unch), BIOC: 3.32 (-0.14), WFD: 7.47 (+0.13), PLMT: 15.79 (+0.17), JAXB: 11.75 (-0.15), SUSQ: 13.13 (+0.07), RDIB: 12.00 (-0.04)

Nasdaq stocks posting largest percentage increases
AP - Thu Nov 13, 5:05PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
ESCA: 13.28 (-0.24), IMDZ: 34.88 (-1.09), OLED: 27.32 (+0.12), FUEL: 18.58 (-0.62), CZR: 16.56 (+0.05), NTIC: 20.00 (-0.75), RESN: 7.18 (-0.01), OREX: 5.57 (-0.29), VBFC: 22.00 (+0.95), FLML: 13.01 (-0.38), ACHN: 13.50 (+0.01), RDI: 11.95 (-0.03), AMOT: 19.04 (-0.23), SUSQ: 13.13 (+0.07), RDIB: 12.00 (-0.04)

Most active Nasdaq-traded stocks
AP - Thu Nov 13, 5:05PM CST
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading:
GILD: 101.99 (-2.21), FB: 74.38 (+0.13), CMCSK: 53.81 (-0.22), ZNGA: 2.68 (-0.05), MSFT: 49.75 (+0.14), INTC: 33.88 (+0.20), GRPN: 7.73 (-0.04), CMCSA: 53.96 (-0.34), AAPL: 114.00 (+1.18), SUSQ: 13.13 (+0.07), CSCO: 26.13 (+0.45)

Wal-Mart and Viacom are big market movers
AP - Thu Nov 13, 3:41PM CST
NEW YORK (AP) — Stocks that moved substantially or traded heavily Thursday on the New York Stock Exchange and the Nasdaq Stock Market:
MNK: 86.33 (-0.63), HAS: 54.79 (-0.19), F: 15.11 (+0.18), ASPS: 51.68 (-3.32), PLUG: 3.75 (-0.31), FUEL: 18.58 (-0.62), M: 62.00 (+0.43), WMT: 82.54 (-0.40), CZR: 16.56 (+0.05), ADT: 35.27 (+0.25), SJM: 100.34 (+0.47), VIA: 72.91 (+1.38), AEO: 13.58 (unch), JCP: 7.24 (+0.14), SUSQ: 13.13 (+0.07), VIAB: 72.69 (+1.49)

Susquehanna Bancshares (SUSQ) Stock Declining Today Amid Investigation Into BB&T Merger
at The Street - Thu Nov 13, 12:16PM CST
Susquehanna Bancshares (SUSQ) stock is down Thursday, after law firm Brodsky & Smith said it's investigating the company relating to its acquisition by BB&T.
SUSQ: 13.13 (+0.07)

Does The End Of QE Portend A New Beginning For Income Investors?
Adam Aloisi - at Seeking Alpha - Thu Nov 13, 11:48AM CST

KO: 42.68 (-0.11), JNJ: 108.35 (-0.72), BBT: 37.60 (+0.02), LHO: 39.13 (-0.07), BP: 40.87 (+0.20), PG: 88.54 (-0.06), CVX: 115.88 (-0.57), CSX: 36.73 (+0.10), SUSQ: 13.13 (+0.07), RLJ: 31.98 (+0.14), FULT: 12.30 (+0.01), UNP: 120.53 (+0.28)

BB&T to Buy Susquehanna for $2.5B: Will it be Accretive? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 11:00AM CST
With an aim to expand its footprints in the Mid-Atlantic region, BB&T (BBT) is set to acquire Susquehanna. The cash-cum-stock transaction is valued at $2.5 billion.
BKYF: 46.71 (+0.11), BBT: 37.60 (+0.02), C: 53.40 (-0.04), SUSQ: 13.13 (+0.07)

Susquehanna Bancshares, Inc. (SUSQ) in Focus: Stock Surges 32.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 8:18AM CST
Susquehanna Bancshares, Inc. (SUSQ) was a big mover last session, as the company saw its shares rise by over 32% on the day.
CXW: 36.07 (-0.08), WPC: 66.14 (-0.51), AKR: 31.53 (-0.29), SUSQ: 13.13 (+0.07)

Downgrade Alert for Susquehanna Bancshares (SUSQ)
Comtex SmarTrend(R) - Thu Nov 13, 7:03AM CST
Susquehanna Bancshares (NASDAQ:SUSQ) was downgraded from Buy to Neutral at Sterne Agee today. The stock closed yesterday at $13.12 on volume of 25.8 million shares, above average daily volume of 1.4 million. Susquehanna Bancshares (NASDAQ:SUSQ) is currently priced 21.5% above its average consensus analyst price target of $10.30. The stock should find initial support at its 200-day moving average (MA) of $10.42 and further support at its 50-day MA of $10.10.
SUSQ: 13.13 (+0.07)

Susquehanna up on takeover
at Investor's Business Daily - Wed Nov 12, 5:54PM CST
Shares of Susquehanna Bancshares (SUSQ) soared 32.5% to 12.12 on news that BB&T (BBT) will acquire the financial services firm in a cash-and-stock deal worth $2.5 bil. The acquisition will expand BB&T's presence in the mid-Atlantic. The transaction...
BBT: 37.60 (+0.02), SUSQ: 13.13 (+0.07)

Look for Shares of Susquehanna Bancshares to Potentially Pullback after Yesterday's 32.53% Rise
Comtex SmarTrend(R) - Wed Nov 12, 3:50PM CST
Susquehanna Bancshares (NASDAQ:SUSQ) traded in a range yesterday that spanned from a low of $13.01 to a high of $13.24. Yesterday, the shares gained 32.5%, which took the trading range above the 3-day high of $9.99 on volume of 25.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
SUSQ: 13.13 (+0.07)

BB&T pushes into Mid-Atlantic with Susquehanna buy
AP - Wed Nov 12, 3:38PM CST
NEW YORK (AP) — BB&T, a commercial bank based in North Carolina, is buying Susquehanna Bancshares in a deal that will broaden the bank's reach into the Mid-Atlantic region.
SUSQ: 13.13 (+0.07)

Stock Market Today: Why Equities Are Running on 'Fumes'
at The Street - Wed Nov 12, 3:19PM CST
The Dow Jones Industrial Average and S&P 500 snap their five-day streak of record closing highs, though markets start a new trend: tiny moves in either direction.
BCS: 14.56 (+0.13), SEAS: 16.90 (-0.12), BBT: 37.60 (+0.02), C: 53.39 (-0.05), HSBC: 50.22 (+0.07), M: 61.99 (+0.42), BAC: 17.17 (-0.05), UBS: 17.56 (+0.02), RBS: 11.80 (+0.05), YHOO: 51.38 (+0.88), FOSL: 107.59 (-2.22), JPM: 60.46 (+0.23), AEO: 13.58 (unch), JCP: 7.24 (+0.14), TWTR: 40.81 (+0.77), SUSQ: 13.13 (+0.07), CSCO: 26.13 (+0.45)

SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of Susquehanna Bancshares, Inc. in Connection with the Sale of the Company -SUSQ
PR Newswire - Wed Nov 12, 2:11PM CST
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Susquehanna Bancshares, Inc. ("Susquehanna"

or the ("Company"

(Nasdaq -SUSQ-News) relating to the proposed acquisition by BB&T Corporation ("BB&T"

.
BBT: 37.60 (+0.02), SUSQ: 13.13 (+0.07)

Stock Market Today: Stocks Flat as Banks Drag on S&P 500
at The Street - Wed Nov 12, 1:58PM CST
U.S. stock markets slip lower on Wednesday as the banking sector drags on the S&P 500.
BCS: 14.56 (+0.13), SEAS: 16.90 (-0.12), PLUG: 3.75 (-0.31), C: 53.39 (-0.05), WMT: 82.54 (-0.40), HSBC: 50.22 (+0.07), M: 61.99 (+0.42), UBS: 17.56 (+0.02), RBS: 11.80 (+0.05), YHOO: 51.38 (+0.88), FOSL: 107.59 (-2.22), JPM: 60.45 (+0.22), AEO: 13.58 (unch), JCP: 7.24 (+0.14), SUSQ: 13.13 (+0.07), DOW: 50.57 (+0.61), CSCO: 26.13 (+0.45)

Why Shares of Susquehanna Bancshares Inc. Rocketed 32% Higher Today
Alex Planes, The Motley Fool - Motley Fool - Wed Nov 12, 12:33PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Susquehanna Bancshares are trading 32%...
BKYF: 46.71 (+0.11), BBT: 37.60 (+0.02), C: 53.40 (-0.04), SUSQ: 13.13 (+0.07)

Is BB&T's $2.5 Billion Shopping Spree for Susquehanna Bancshares a Good Idea?
at The Street - Wed Nov 12, 12:25PM CST
It's best for investors to wait for clearer signs that BB&T can execute its expansion plans but not hurt its bottom line.
FITB: 20.24 (-0.07), BKYF: 46.71 (+0.11), BBT: 37.60 (+0.02), C: 53.40 (-0.04), STI: 39.70 (-0.08), SUSQ: 13.13 (+0.07)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Surfing Dogs Ride Waves, Support Orphan Pets

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

First-Time Homeowners: Unseen Pitfalls of Insurance

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

GORGIE Unleashes Berry Burst: Target's New Drink Star

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Trial Disappointment: No Significant Gains in NSCLC

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Ris-Rez May Set New Standard in Relapsed SCLC

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

MRI Surveillance Gains Ground in Lung Cancer Care

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....